| Production of 177Lu for Targeted Radionuclide Therapy: Available Options A Dash, MRA Pillai, FF Knapp Nuclear medicine and molecular imaging 49, 85-107, 2015 | 429 | 2015 |
| Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications S Banerjee, MRA Pillai, FF Knapp Chemical reviews 115 (8), 2934-2974, 2015 | 361 | 2015 |
| Evolution of Tc-99m in diagnostic radiopharmaceuticals S Banerjee, MRA Pillai, N Ramamoorthy Seminars in nuclear medicine 31 (4), 260-277, 2001 | 351 | 2001 |
| Production logistics of 177Lu for radionuclide therapy MRA Pillai, S Chakraborty, T Das, M Venkatesh, N Ramamoorthy Applied radiation and isotopes 59 (2-3), 109-118, 2003 | 247 | 2003 |
| Fluorine-18 radiopharmaceuticals beyond [18F] FDG for use in oncology and neurosciences HH Coenen, PH Elsinga, R Iwata, MR Kilbourn, MRA Pillai, MGR Rajan, ... Nuclear medicine and biology 37 (7), 727-740, 2010 | 179 | 2010 |
| Sustained availability of 99mTc: possible paths forward MRA Pillai, A Dash, FFR Knapp Journal of Nuclear Medicine 54 (2), 313-323, 2013 | 161 | 2013 |
| Peptide receptor radionuclide therapy: an overview A Dash, S Chakraborty, MRA Pillai, FF Knapp Jr Cancer Biotherapy and Radiopharmaceuticals 30 (2), 47-71, 2015 | 159 | 2015 |
| Targeted radionuclide therapy-an overview A Dash, F F.(Russ) Knapp, M Ra Pillai Current radiopharmaceuticals 6 (3), 152-180, 2013 | 146 | 2013 |
| Options to meet the future global demand of radionuclides for radionuclide therapy T Das, MRA Pillai Nuclear medicine and biology 40 (1), 23-32, 2013 | 126 | 2013 |
| Diagnostic value of 68Ga PSMA-11 PET/CT imaging of brain tumors—preliminary analysis A Sasikumar, A Joy, MRA Pillai, R Nanabala, PG Jayaprakash, ... Clinical nuclear medicine 42 (1), e41-e48, 2017 | 124 | 2017 |
| 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma A Sasikumar, A Joy, R Nanabala, MRA Pillai, B Thomas, KR Vikraman European journal of nuclear medicine and molecular imaging 43, 795-796, 2016 | 122 | 2016 |
| Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy R Chakravarty, U Pandey, RB Manolkar, A Dash, M Venkatesh, ... Nuclear medicine and biology 35 (2), 245-253, 2008 | 122 | 2008 |
| 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis S Chakraborty, T Das, S Banerjee, L Balogh, PR Chaudhari, HD Sarma, ... Cancer biotherapy & radiopharmaceuticals 23 (2), 202-213, 2008 | 114 | 2008 |
| Rhenium-188: availability from the 188W/188Re generator and status of current applications M RA Pillai, A Dash, F F Knapp Current radiopharmaceuticals 5 (3), 228-243, 2012 | 110 | 2012 |
| 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation T Das, S Chakraborty, PR Unni, S Banerjee, G Samuel, HD Sarma, ... Applied Radiation and Isotopes 57 (2), 177-184, 2002 | 109 | 2002 |
| 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation S Chakraborty, T Das, PR Unni, HD Sarma, G Samuel, S Banerjee, ... Nuclear medicine communications 23 (1), 67-74, 2002 | 109 | 2002 |
| Availability of yttrium-90 from strontium-90: a nuclear medicine perspective R Chakravarty, A Dash Cancer Biotherapy and Radiopharmaceuticals 27 (10), 621-641, 2012 | 108 | 2012 |
| 99Mo/99mTc separation: An assessment of technology options A Dash, FFR Knapp Jr, MRA Pillai Nuclear medicine and biology 40 (2), 167-176, 2013 | 106 | 2013 |
| Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer MRA Pillai, R Nanabala, A Joy, A Sasikumar, FFR Knapp Nuclear medicine and biology 43 (11), 692-720, 2016 | 103 | 2016 |
| 170Tm-EDTMP: a potential cost-effective alternative to 89SrCl2 for bone pain palliation T Das, S Chakraborty, HD Sarma, P Tandon, S Banerjee, M Venkatesh, ... Nuclear medicine and biology 36 (5), 561-568, 2009 | 84 | 2009 |
Haladhar Dev SarmaScientific Officer, Bhabha Atomic Research Centre, IndiaVerified email at barc.gov.in
Tapas Kumar DasProfessor of Theoretical Astrophysics, HRI Dept of Atomic Energy Govt. of IndiaVerified email at hri.res.in
Ashutosh DashBhabha Atomic Research Center, MumbaiVerified email at barc.gov.in
Rubel ChakravartyBhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, IndiaVerified email at barc.gov.in
Dr. Raviteja Nanabala, PhDChief radiochemist at Molecular Cyclotrons Pvt Ltd and Molecular Global Group of CompaniesVerified email at molecularglobal.com
Pradip ChaudhariComparative Oncology Program & TranslatSmall Animal Imaging Facility, Advanced Centre for TreatmentVerified email at actrec.gov.in
Andras PolyakROTOP RadiopharmacyVerified email at rotop-pharmaka.de
Shanmugaperumal KannanscientistVerified email at barc.gov.inK. V. VimalnathBhabha Atomic Research CentreVerified email at barc.gov.in
Madhava B MalliaBhabha Atomic Research Centre, Mumbai and Homi Bhabha National Institute, MumbaiVerified email at barc.gov.in
Lajos P. BaloghEditor-in-Chief, Precision NanomedicineVerified email at precisionnanomedicine.com